| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase POSITIVE ION MODE | ASPC-C-1 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
| Reversed phase POSITIVE ION MODE | ASPC-C-2 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
| Reversed phase POSITIVE ION MODE | ASPC-C-3 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
| Reversed phase POSITIVE ION MODE | ASPC-C-4 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
| Reversed phase POSITIVE ION MODE | ASPC-C-5 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
| Reversed phase POSITIVE ION MODE | ASPC-GI-1 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
| Reversed phase POSITIVE ION MODE | ASPC-GI-2 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
| Reversed phase POSITIVE ION MODE | ASPC-GI-3 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
| Reversed phase POSITIVE ION MODE | ASPC-GI-4 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
| Reversed phase POSITIVE ION MODE | ASPC-GI-5 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
| Reversed phase POSITIVE ION MODE | ASPC-G-1-r002 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |
| Reversed phase POSITIVE ION MODE | ASPC-G-2 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |
| Reversed phase POSITIVE ION MODE | ASPC-G-3 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |
| Reversed phase POSITIVE ION MODE | ASPC-G-4 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |
| Reversed phase POSITIVE ION MODE | ASPC-G-5 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |
| Reversed phase NEGATIVE ION MODE | ASPC-C-1 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
| Reversed phase NEGATIVE ION MODE | ASPC-C-2 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
| Reversed phase NEGATIVE ION MODE | ASPC-C-3 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
| Reversed phase NEGATIVE ION MODE | ASPC-C-4 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
| Reversed phase NEGATIVE ION MODE | ASPC-C-5 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
| Reversed phase NEGATIVE ION MODE | ASPC-GI-1 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
| Reversed phase NEGATIVE ION MODE | ASPC-GI-2 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
| Reversed phase NEGATIVE ION MODE | ASPC-GI-3 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
| Reversed phase NEGATIVE ION MODE | ASPC-GI-4 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
| Reversed phase NEGATIVE ION MODE | ASPC-GI-5 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
| Reversed phase NEGATIVE ION MODE | ASPC-G-1-r002 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |
| Reversed phase NEGATIVE ION MODE | ASPC-G-2 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |
| Reversed phase NEGATIVE ION MODE | ASPC-G-3 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |
| Reversed phase NEGATIVE ION MODE | ASPC-G-4 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |
| Reversed phase NEGATIVE ION MODE | ASPC-G-5 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |
Return to study ST002122 main page
Download data matrix(Functional metabolic molecules were identified as novel therapeutic targets to facilitate gemcitabine treatment against pancreatic cancer (Cells metabolomics) Reversed phase POSITIVE ION MODE)
Download data matrix(Functional metabolic molecules were identified as novel therapeutic targets to facilitate gemcitabine treatment against pancreatic cancer (Cells metabolomics) Reversed phase NEGATIVE ION MODE)
- Metabolomics Workbench
|